Anti-neoplastic effects of Chrysanthemum indicum extract on a human hypopharyngeal squamous cell carcinoma cell line
4 affiliations
- 1Department of Natural Biotechnology, Nanhua University, Chiayi 622301, Taiwan, R.O.C.
- 2School of Medicine, I-Shou University, Kaohsiung 824005, Taiwan, R.O.C.
- 3Department of Emergency Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei 23142, Taiwan, R.O.C.
- 4Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung 81362, Taiwan, R.O.C.
Abstract
Hypopharyngeal squamous cell carcinoma (HSCC) is an aggressive malignancy associated with poor clinical outcomes and limited therapeutic options. Natural products, such as Chrysanthemum indicum (CI) extract, represent potential candidates for anticancer drug development; however, their therapeutic potential against HSCC remains unclear. The present study investigated the antitumor activity of CI crude extract in the human HSCC cell line FaDu and explored the underlying molecular mechanisms. Intracellular oxidative activity following CI treatment was quantified using 2',7'-dichlorodihydrofluorescein diacetate flow cytometry. The expression of proteins associated with cell survival and apoptosis was evaluated using western blotting, while cell viability was assessed using a Cell Counting Kit-8 assay. CI treatment notably reduced FaDu cell viability in a dose- and time-dependent manner. Flow cytometric analysis revealed an acute, concentration-dependent increase in intracellular oxidative activity following CI treatment, which was effectively reversed through pretreatment with the antioxidant N-acetylcysteine. Increased intracellular oxidative activity was accompanied by reduced expression of the endoplasmic reticulum stress sensor protein kinase R-like endoplasmic reticulum kinase, also known as eukaryotic translation initiation factor 2 α kinase 3 (EIF2AK3), decreased phosphorylated (p)-Akt levels and a reduced p-Akt/total Akt ratio. These changes were accompanied by marked dose-dependent depletion of the anti-apoptotic protein B-cell lymphoma 2. Overall, CI treatment reduced FaDu cell viability and was associated with increased intracellular oxidative activity, reduced EIF2AK3 expression and decreased Akt activation. These findings support the potential antitumor activity of CI in HSCC cells and provide a rationale for further mechanistic and in vivo investigation.
Related
- Transcriptome analysis and gene mining of chrysanthemum(Chrysanthemum indicum)in response to low temperature stress.
- Testing immune priming failure in laryngeal squamous cell carcinoma: direct evidence, unresolved links, and a compartment-resolved framework
- Chemopreventive potential of Styrax liquidus in a DMBA-induced oral squamous cell carcinoma model
- Novel Target Combinations in Lung Squamous Cell Carcinoma proposed by the Emet AI Research Environment and supported by discovery stage experimentation
- Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma
BibTeX
@article{liu2026antineoplastic,
title = {{Anti-neoplastic effects of Chrysanthemum indicum extract on a human hypopharyngeal squamous cell carcinoma cell line}},
author = {Ching-Wen Liu and Li-Ching Chang and Ting-Ting Lai and Hsiao-Chi Lai},
journal = {Oncology Letters},
year = {2026},
month = oct,
doi = {10.3892/ol.2026.15910},
url = {https://europepmc.org/article/PMC/PMC13717319},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Anti-neoplastic effects of Chrysanthemum indicum extract on a human hypopharyngeal squamous cell carcinoma cell line
AU - Ching-Wen Liu
AU - Li-Ching Chang
AU - Ting-Ting Lai
AU - Hsiao-Chi Lai
PY - 2026
DA - 2026/10/16
JO - Oncology Letters
DO - 10.3892/ol.2026.15910
UR - https://europepmc.org/article/PMC/PMC13717319
AB - Hypopharyngeal squamous cell carcinoma (HSCC) is an aggressive malignancy associated with poor clinical outcomes and limited therapeutic options. Natural products, such as Chrysanthemum indicum (CI) extract, represent potential candidates for anticancer drug development; however, their therapeutic potential against HSCC remains unclear. The present study investigated the antitumor activity of CI crude extract in the human HSCC cell line FaDu and explored the underlying molecular mechanisms. Intracellular oxidative activity following CI treatment was quantified using 2',7'-dichlorodihydrofluorescein diacetate flow cytometry. The expression of proteins associated with cell survival and apoptosis was evaluated using western blotting, while cell viability was assessed using a Cell Counting Kit-8 assay. CI treatment notably reduced FaDu cell viability in a dose- and time-dependent manner. Flow cytometric analysis revealed an acute, concentration-dependent increase in intracellular oxidative activity following CI treatment, which was effectively reversed through pretreatment with the antioxidant N-acetylcysteine. Increased intracellular oxidative activity was accompanied by reduced expression of the endoplasmic reticulum stress sensor protein kinase R-like endoplasmic reticulum kinase, also known as eukaryotic translation initiation factor 2 α kinase 3 (EIF2AK3), decreased phosphorylated (p)-Akt levels and a reduced p-Akt/total Akt ratio. These changes were accompanied by marked dose-dependent depletion of the anti-apoptotic protein B-cell lymphoma 2. Overall, CI treatment reduced FaDu cell viability and was associated with increased intracellular oxidative activity, reduced EIF2AK3 expression and decreased Akt activation. These findings support the potential antitumor activity of CI in HSCC cells and provide a rationale for further mechanistic and in vivo investigation.
SN - 1792-1074
SN - 1792-1082
ER -